Pharmaceutical compositions comprising anti-teratogenic agents are
disclosed. Additionally, pharmaceutical compositions comprising
anti-neoplastic agents and anti-teratogenic agents are disclosed. Methods
of assessing the teratogenicity of a compound are disclosed. The present
invention further comprises applications of the aforementioned
compositions and methods.